Cabazitaxel has been given regulatory approval in the USA and is under consideration by the European Medicines Agency and other global approval committees to be used to extend life expectancy in prostate cancer patients…
View full post on Prostate / Prostate Cancer News From Medical News Today
Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that the launch and uptake of nine emerging therapies will drive the prostate cancer drug market to more than double from nearly $4 billion in 2009 to $8.4 billion in 2019 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan…
View full post on Prostate / Prostate Cancer News From Medical News Today
Prostate cancer is the second leading cause of cancer-related deaths in men with an estimated 192,280 new cases diagnosed in the US in 2009 (Jemal 2009). Diet is considered one of the most important controllable risk factors for inflammation and prostate diseases including benign prostatic hyperplsia (BPH), prostatitis, and prostate cancer…
View full post on Prostate / Prostate Cancer News From Medical News Today
Recent genetic association studies have uncovered a number of DNA variants associated with prostate cancer. However, some of these risk variants lie outside of genes, posing a challenge to researchers working to understand the biology of cancer…
View full post on Prostate / Prostate Cancer News From Medical News Today
With a new study showing the PSA test reduces the prostate cancer death rate by 44 percent, ZERO The Project to End Prostate Cancer demands an apology for all at risk of the disease from the American Cancer Society, which has long discounted the importance of prostate cancer testing. “It’s time to ‘Man Up’ and admit they were wrong,” said ZERO CEO Skip Lockwood…
View full post on Prostate / Prostate Cancer News From Medical News Today
Johns Hopkins experts have found that men enrolled in an active surveillance program for prostate cancer that eventually needed surgery to remove their prostates fared just as well as men who opted to remove the gland immediately, except if a follow-up biopsy during surveillance showed high-grade cancer…
View full post on Prostate / Prostate Cancer News From Medical News Today
In what could lead to a major advance in the treatment of prostate cancer, scientists now know exactly why polyphenols in red wine and green tea inhibit cancer growth. This new discovery, published online in The FASEB Journal, explains how antioxidants in red wine and green tea produce a combined effect to disrupt an important cell signaling pathway necessary for prostate cancer growth…
View full post on Prostate / Prostate Cancer News From Medical News Today
UroToday.com – In the February 15, 2010 issue of Clinical Cancer Research, Drs. Eleni Efstathiou and Christopher Logothetis present their paradigm regarding the prostate cancer (CaP) tumor microenvironment and how it contributes to CaP progression and response to therapy…
View full post on Prostate / Prostate Cancer News From Medical News Today